tiprankstipranks
Pieris Pharmaceuticals (PIRS)
NASDAQ:PIRS

Pieris Pharmaceuticals (PIRS) Ownership - Who Owns Pieris Pharmaceuticals?

581 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
May 30, 2023Bought$8500

Recent Hedge Fund Trading Activity

Currently, No Data Available
Date
Firm
Activity
Value

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
885,502Institution71.60%9,935,332
885,502Institution71.60%9,935,332
745,407Institution60.27%8,363,467
116,500Institution9.42%1,307,130
81,145Institution6.56%910,447
35,732Institution2.89%400,913
29,063Institution2.35%326,087
16,645Institution1.35%186,757

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
885,502Institution71.60%9,935,332
745,407Institution60.27%8,363,467
116,500Institution9.42%1,307,130
81,145Institution6.56%910,447
35,732Institution2.89%400,913
29,063Institution2.35%326,087
16,645Institution1.35%186,757

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
885,502Institution71.60%162,224

FAQ

Who Owns Pieris Pharmaceuticals (PIRS)?
Currently, no data Available
What percentage of Pieris Pharmaceuticals (PIRS) stock is held by institutional investors?
Currently, no data Available
What percentage of Pieris Pharmaceuticals (PIRS) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Pieris Pharmaceuticals (PIRS)?
Vanguard owns the most shares of Pieris Pharmaceuticals (PIRS).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis